1871. Deputy Cormac Devlin asked the Minister for Children, Disability and Equality when a review of the Decision Support Service is scheduled to take place to ensure it is fit for purpose and serving the needs of service users and practitioners; and if she will make a statement on the matter. [44616/25]
2041. Deputy Cormac Devlin asked the Minister for Health if he has received from the Minister for Health the materials required under regulation 9 of S.I. No. 413 of 2022 in respect of CORU’s July 2025 Standards and Criteria for counsellors and psychotherapists; if his Department has notified the European Commission accordingly; and, in view of the psychotherapy entry requirement being set at NFQ Level 9 and counsell…
2080. Deputy Cormac Devlin asked the Minister for Health the number of advance healthcare directives submitted to the Decision Support Service, by month since April 2023; the number of decisions made each month in respect of such submissions, including any refusals, in tabular form; and if she will make a statement on the matter. [44615/25]
2200. Deputy Cormac Devlin asked the Minister for Health if she is aware of an issue in relation to the organ donation opt-out register (details supplied); and if she will make a statement on the matter. [45044/25]
2201. Deputy Cormac Devlin asked the Minister for Health to provide an update on the number of applications processed by the new organ donation opt-out register system, by month, in tabular form; and if she will make a statement on the matter. [45045/25]
2202. Deputy Cormac Devlin asked the Minister for Health to provide an update on the number of complaints received by the HSE in relation to the new organ donation opt-out register system, by month, in tabular form; if a manual mechanism will be created to allow individuals opt out where the system fails to record their preference; and if she will make a statement on the matter. [45046/25]
2618. Deputy Cormac Devlin asked the Minister for Health if she will provide an update on the NCPE appraisal of ritlecitinib (litfulo) for severe alopecia areata, including current stage, any ongoing HSE pricing and reimbursement engagement with the applicant; the expected timelines for a decision and proposed prescribing setting if approved; and if she will make a statement on the matter. [46999/25]
2619. Deputy Cormac Devlin asked the Minister for Health if an application has been received by the HSE for pricing and reimbursement of baricitinib for the alopecia areata indication; if not, if the HSE or her Department has engaged with the marketing authorisation holder regarding a submission; and if she will make a statement on the matter. [47000/25]
2620. Deputy Cormac Devlin asked the Minister for Health if her Department, the HSE or the HPRA has engaged with the manufacturer of deuruxolitinib (leqselvi) regarding plans for EU submission and availability in Ireland; if any named-patient or compassionate access requests have been received; and if she will make a statement on the matter. [47001/25]
2621. Deputy Cormac Devlin asked the Minister for Health if JAK inhibitor treatments for severe alopecia areata, where reimbursed will be provided via the high tech arrangement; the intended initiation and monitoring setting; the proposed stop rules; the estimated annual budget impact and eligible patient numbers; and if she will make a statement on the matter. [47002/25]
2622. Deputy Cormac Devlin asked the Minister for Health the number of patients treated for alopecia areata with JAK inhibitors in public hospitals in each of the past three years, by CHO and by medicine, including any named-patient access, and associated monitoring protocols; and if she will make a statement on the matter. [47003/25]
2623. Deputy Cormac Devlin asked the Minister for Health if she will publish a national clinical pathway for alopecia areata within the HSE Model of Care for Dermatology (details supplied); and if she will make a statement on the matter. [47004/25]
2624. Deputy Cormac Devlin asked the Minister for Health the number of public dermatology centres that provide topical immunotherapy for example DPCP or SADBE for extensive alopecia areata; the number treated in each of the past three years; the average waiting times; if capacity expansion is planned; and if she will make a statement on the matter. [47005/25]
2625. Deputy Cormac Devlin asked the Minister for Health the details of the availability of intralesional corticosteroid clinics for patchy alopecia areata, by hospital group; the average wait time from referral; the actions to standardise access nationally; and if she will make a statement on the matter. [47006/25]
2626. Deputy Cormac Devlin asked the Minister for Health if the HSE will establish a national registry to capture outcomes for alopecia areata (details supplied); the proposed data controller and governance; the expected start date; and if she will make a statement on the matter. [47007/25]
2627. Deputy Cormac Devlin asked the Minister for Health if she will issue guidance on vaccination including the shingles vaccination and infection-risk mitigation for patients commencing JAK inhibitors for alopecia areata, including funding and delivery arrangements; and if she will make a statement on the matter. [47008/25]
2628. Deputy Cormac Devlin asked the Minister for Health for Ireland’s position on the amendments to the international health regulations adopted by the World Health Assembly on 1 June 2024; if Ireland has lodged any reservation or objection to the amendments with the World Health Organisation; the timeline for the Government’s consideration of the amendments; the details around the impact of the amendments; and if s…
2629. Deputy Cormac Devlin asked the Minister for Health if she will clarify the eligibility of dermatology outpatient consultations for alopecia areata under the Cross-Border Healthcare Directive; the documentation required; whether take-home medicinal products prescribed abroad for alopecia areata are reimbursable under the CBD scheme; and if she will make a statement on the matter. [47014/25]
2630. Deputy Cormac Devlin asked the Minister for Health the number of dermatology referrals for alopecia areata supported by the national treatment purchase fund (NTPF) in each of the past three years; the median and 95th percentile waits before and after NTPF intervention; and if she will make a statement on the matter. [47015/25]
2631. Deputy Cormac Devlin asked the Minister for Health if she will ensure access to psychological support services for patients with visible hair loss conditions, including alopecia areata and scarring alopecias; the referral pathway from dermatology clinics; the planned service improvements; and if she will make a statement on the matter. [47016/25]
2632. Deputy Cormac Devlin asked the Minister for Health if the HSE medicines management programme will include alopecia areata therapies in its horizon-scanning outputs and publish periodic patient friendly updates on access status for new treatments; and if she will make a statement on the matter. [47017/25]
2645. Deputy Cormac Devlin asked the Minister for Health the number of hospitals with islandable power or at least 7–14 days’ backup power and water resilience; the planned upgrades for 2025–2027, by hospital group; the associated funding, in tabular form; and if she will make a statement on the matter. [47191/25]
2646. Deputy Cormac Devlin asked the Minister for Health the current days of cover for the top 100 essential medicines, by category; the medicines experiencing repeated shortages since 2023; the plan to establish a rotating national reserve and domestic fill finish capacity; and if she will make a statement on the matter. [47208/25]
2647. Deputy Cormac Devlin asked the Minister for Health the number of hospitals with islandable power, on-site oxygen generation and at least 7 to 14 days fuel and water resilience; the capital works underway to address gaps; the schedule for annual black-start drills across acute sites, in tabular form; and if she will make a statement on the matter. [47209/25]
2665. Deputy Cormac Devlin asked the Minister for Health the status of all-island health service collaborations supported by the Shared Island Fund, including the expansion of bespoke all-island services building on paediatric cardiac care, specifying funded capital elements, service start dates and evaluation metrics; and if she will make a statement on the matter. [47402/25]